Margaret A. MacRae

  • Citations Per Year
Learn More
Background: Gemcitabine (G) has shown activity in mantle cell lymphoma (MCL) as a single agent. The combination of mitoxantrone (M) and rituximab (R) is also active in MCL. The primary objective of this study was to determine the efficacy of G+M+R in relapsed or refractory MCL. Patients and Methods: Sixteen patients were enrolled between April 2005 and(More)
A 15-year-old girl with acute myelomonocytic leukemia in bone marrow remission presented with signs and symptoms of an intracranial mass lesion. A computed tomographic scan revealed a large cystic lesion in the left posterior parietal lobe, which biopsy proved to be a granulocytic sarcoma. She responded well to a combined treatment program utilizing(More)
  • 1